Page last updated: 2024-11-02

pantoprazole and Chemical Dependence

pantoprazole has been researched along with Chemical Dependence in 1 studies

Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.

Research Excerpts

ExcerptRelevanceReference
"To quantify the effect of blinded dosage reduction after long-term therapy on symptom control and quality of life while assessing pharmacological and placebo needs."2.75Pharmacological dependency in chronic treatment of gastroesophageal reflux disease: a randomized controlled clinical trial. ( de Wit, NJ; Grobbee, DE; Numans, ME; Quartero, AO; van der Velden, AW, 2010)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
van der Velden, AW1
de Wit, NJ1
Quartero, AO1
Grobbee, DE1
Numans, ME1

Trials

1 trial available for pantoprazole and Chemical Dependence

ArticleYear
Pharmacological dependency in chronic treatment of gastroesophageal reflux disease: a randomized controlled clinical trial.
    Digestion, 2010, Volume: 81, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Dose-Response Relationship, Drug; Double-Blind Method; Drug

2010